相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Analgesic Opioid Ligand Discovery Based on Nonmorphinan Scaffolds Derived from Natural Sources
Maree T. Smith et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Structural Insights Accelerate the Discovery of Opioid Alternatives
Tao Che et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 90, 2021 (2021)
Opioid Analgesia and Opioid-Induced Adverse Effects: A Review
Alok K. Paul et al.
PHARMACEUTICALS (2021)
LP1 and LP2: Dual-Target MOPr/DOPr Ligands as Drug Candidates for Persistent Pain Relief
Lorella Pasquinucci et al.
MOLECULES (2021)
Morphine-induced respiratory depression is independent of β-arrestin2 signalling
Andrea Kliewer et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Intracerebroventricular administration of CYX-6, a potent μ-opioid receptor agonist, a δ- and κ-opioid receptor antagonist and a biased ligand at μ, δ & κ-opioid receptors, evokes antinociception with minimal constipation and respiratory depression in rats in contrast to morphine
Mohammad Zafar Imam et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Novel N-Substituted Benzomorphan-Based Compounds: From MOR-Agonist/DOR-Antagonist to Biased/Unbiased MOR Agonists
Lorella Pasquinucci et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
In vitro profiling of opioid ligands using the cAMP formation inhibition assay and the β-arrestin2 recruitment assay: No two ligands have the same profile
Andy Kuo et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Opioid analgesia: recent developments
Christoph Stein
CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE (2020)
Biased Opioid Ligands
Abdelfattah Faouzi et al.
MOLECULES (2020)
Critical Assessment of G Protein-Biased Agonism at the μ-Opioid Receptor
Alexander Gillis et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2020)
APOLLO-1: a randomized placebo and active-controlled phase III study investigating oliceridine (TRV130), a G protein-biased ligand at the μ-opioid receptor, for management of moderate-to-severe acute pain following bunionectomy
Eugene R. Viscusi et al.
JOURNAL OF PAIN RESEARCH (2019)
Multivalent peptide and peptidomimetic ligands for the treatment of pain without toxicities and addiction
Victor J. Hruby
PEPTIDES (2019)
APOLLO-2: A Randomized, Placebo and Active-Controlled Phase III Study Investigating Oliceridine (TRV130), a G Protein-Biased Ligand at the μ-Opioid Receptor, for Management of Moderate to Severe Acute Pain Following Abdominoplasty
Neil K. Singla et al.
PAIN PRACTICE (2019)
The novel mu-opioid receptor agonist PZM21 depresses respiration and induces tolerance to antinociception
Rob Hill et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
In vivo profiling of four centrally administered opioids for antinociception, constipation and respiratory depression: Between-colony differences in Sprague Dawley rats
Andy Kuo et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2018)
In vitro and in vivo Pharmacological Activities of 14-O-Phenylpropyloxymorphone, a Potent Mixed Mu/Delta/Kappa-Opioid Receptor Agonist With Reduced Constipation in Mice
Roberta Lattanzi et al.
FRONTIERS IN PHARMACOLOGY (2018)
Targeting multiple opioid receptors - improved analgesics with reduced side effects?
Thomas Guenther et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Effects of acute and repeated treatment with the biased mu opioid receptor agonist TRV130 (oliceridine) on measures of antinociception, gastrointestinal function, and abuse liability in rodents
Ahmad A. Altarifi et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2017)
Multitarget opioid ligands in pain relief: New players in an old game
Rita Turnaturi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Structure-based discovery of opioid analgesics with reduced side effects
Aashish Manglik et al.
NATURE (2016)
Mixed MOP/DOP agonist biphalin elicits anti-transit effect in mouse models mimicking diarrhea-predominant irritable bowel syndrome symptoms
Marta Zielinska et al.
PHARMACOLOGICAL REPORTS (2016)
In vivo profiling of seven common opioids for antinociception, constipation and respiratory depression: no two opioids have the same profile
A. Kuo et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Endomorphin analogues with mixed μ-opioid (MOP) receptor agonism/δ-opioid (DOP) receptor antagonism and lacking β-arrestin2 recruitment activity
Jun Cai et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Theoretical and practical applications of the intracerebroventricular route for CSF sampling and drug administration in CNS drug discovery research: A mini review
Andy Kuo et al.
JOURNAL OF NEUROSCIENCE METHODS (2014)
Identification of a μ-δ opioid receptor heteromer-biased agonist with antinociceptive activity
Ivone Gomes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Opioid receptors: toward separation of analgesic from undesirable effects
Ping-Yee Law et al.
TRENDS IN BIOCHEMICAL SCIENCES (2013)
A G Protein-Biased Ligand at the μ-Opioid Receptor Is Potently Analgesic with Reduced Gastrointestinal and Respiratory Dysfunction Compared with Morphines
Scott M. DeWire et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Identification of a dual δ OR antagonist/μ OR agonist as a potential therapeutic for diarrhea-predominant Irritable Bowel Syndrome (IBS-d)
Henry J. Breslin et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Modulation of gastrointestinal function by MuDelta, a mixed μ opioid receptor agonist/μ opioid receptor antagonist
P. R. Wade et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Excitatory and inhibitory effects of opioid agonists on respiratory motor output produced by isolated brainstems from adult turtles (Trachemys)
Stephen M. Johnson et al.
RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY (2010)
Nausea and Vomiting Side Effects with Opioid Analgesics during Treatment of Chronic Pain: Mechanisms, Implications, and Management Options
Frank Porreca et al.
PAIN MEDICINE (2009)
Comparative studies of the neuro-excitatory behavioural effects of morphine-3-glucuronide and dynorphin A(2-17) following spinal and supraspinal routes of administration
Kamondanai Hemstapat et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2009)
Inhibitory and excitatory effects of μ-, δ-, and κ- opioid receptor activation on breathing in awake turtles, Trachemys scripta
Stephen M. Johnson et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2008)
Morphine side effects in beta-arrestin 2 knockout mice
KM Raehal et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Morphine-3-glucuronide's neuro-excitatory effects are mediated via indirect activation of N-methyl-D-aspartic acid receptors:: Mechanistic studies in embryonic cultured hippocampal neurones
K Hemstapat et al.
ANESTHESIA AND ANALGESIA (2003)
Exploring the opioid system by gene knockout
BL Kieffer et al.
PROGRESS IN NEUROBIOLOGY (2002)
Neuroexcitatory effects of morphine and hydromorphone: Evidence implicating the 3-glucuronide metabolites
MT Smith
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2000)
分享论文
